提高 HIV 感染吸毒者获得和利用医疗保健服务以及坚持抗逆转录病毒治疗的策略。
Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.
机构信息
Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York 10467, USA.
出版信息
Subst Use Misuse. 2011;46(2-3):218-32. doi: 10.3109/10826084.2011.522840.
Abstract
We review five innovative strategies to improve access, utilization, and adherence for HIV-infected drug users and suggest areas that need further attention. In addition, we highlight two innovative programs. The first increases access and utilization through integrated HIV and opioid addiction treatment with buprenorphine in a community health center, and the second incorporates adherence counseling for antiretroviral therapy in methadone programs. Preliminary evaluations demonstrated that these strategies may improve both HIV and opioid addiction outcomes and may be appropriate for wider dissemination. Further refinement and expansion of strategies to improve outcomes of HIV-infected drug users is warranted.
摘要
我们回顾了五项创新策略，以改善 HIV 感染者和吸毒者的获得途径、利用情况和治疗依从性，并提出了需要进一步关注的领域。此外，我们还重点介绍了两个创新项目。第一个项目是在社区卫生中心通过将 HIV 治疗和阿片类药物成瘾治疗与丁丙诺啡相结合，增加获得途径并提高利用率；第二个项目则是在美沙酮项目中纳入对艾滋病病毒治疗的依从性咨询。初步评估表明，这些策略可能会改善 HIV 和阿片类药物成瘾的治疗效果，并且可能适合更广泛的推广。需要进一步完善和扩大这些策略，以改善 HIV 感染者和吸毒者的治疗效果。
相似文献
1
Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.
Subst Use Misuse. 2011;46(2-3):218-32. doi: 10.3109/10826084.2011.522840.
2
Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis.
AIDS Behav. 2010 Aug;14(4):731-47. doi: 10.1007/s10461-008-9489-7. Epub 2008 Nov 20.
3
Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
HIV Med. 2019 Oct;20(9):606-614. doi: 10.1111/hiv.12777. Epub 2019 Jul 29.
4
Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.
J Urban Health. 2011 Jun;88(3):545-55. doi: 10.1007/s11524-011-9562-9.
5
"We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.
AIDS Care. 2010 Nov;22(11):1305-13. doi: 10.1080/09540121003758515.
6
What do HIV-positive drug users' experiences tell us about their antiretroviral medication-taking? An international integrated literature review.
Addiction. 2020 Apr;115(4):623-652. doi: 10.1111/add.14857. Epub 2019 Nov 19.
7
Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
AIDS Care. 2011 Aug;23(8):980-7. doi: 10.1080/09540121.2010.543882.
8
Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.
Life Sci. 2011 May 23;88(21-22):948-52. doi: 10.1016/j.lfs.2010.09.025. Epub 2010 Oct 1.
9
Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
Addiction. 2010 May;105(5):907-13. doi: 10.1111/j.1360-0443.2010.02905.x. Epub 2010 Mar 10.
10
Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.
J Assoc Nurses AIDS Care. 2017 Jan-Feb;28(1):85-94. doi: 10.1016/j.jana.2016.09.007. Epub 2016 Sep 22.
引用本文的文献
1
Comprehensive Communication for a Syndemic Approach to HIV Care: A Framework for Enhancing Health Communication Messages for People Living with HIV.
Int J Environ Res Public Health. 2025 Aug 7;22(8):1231. doi: 10.3390/ijerph22081231.
2
Distrust in the Health Care System and Adherence to Direct-Acting Antiviral Therapy among People with Hepatitis Who Inject Drugs.
Viruses. 2024 Aug 16;16(8):1304. doi: 10.3390/v16081304.
3
Mental Health, ART Adherence, and Viral Suppression Among Adolescents and Adults Living with HIV in South Africa: A Cohort Study.
AIDS Behav. 2023 Jun;27(6):1849-1861. doi: 10.1007/s10461-022-03916-x. Epub 2023 Jan 2.
4
Cross-training needs among community-based clinicians in HIV and substance use.
BMC Med Educ. 2022 Aug 19;22(1):629. doi: 10.1186/s12909-022-03682-3.
5
The Past, Present, and Future of PrEP implementation Among People Who Use Drugs.
Curr HIV/AIDS Rep. 2021 Aug;18(4):328-338. doi: 10.1007/s11904-021-00556-z. Epub 2021 Apr 27.
6
Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.
Expert Rev Clin Pharmacol. 2019 Dec;12(12):1129-1143. doi: 10.1080/17512433.2019.1698946.
7
Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
HIV Med. 2019 Oct;20(9):606-614. doi: 10.1111/hiv.12777. Epub 2019 Jul 29.
8
Integration of care for HIV and opioid use disorder.
AIDS. 2019 Apr 1;33(5):873-884. doi: 10.1097/QAD.0000000000002125.
9
Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions.
BMC Public Health. 2019 Jan 8;19(1):31. doi: 10.1186/s12889-018-6314-8.
10
Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Harm Reduct J. 2018 Nov 12;15(1):55. doi: 10.1186/s12954-018-0263-5.
本文引用的文献
1
Buprenorphine treatment in an urban community health center: what to expect.
Fam Med. 2008 Jul-Aug;40(7):500-6.
2
Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review.
Addiction. 2008 Aug;103(8):1242-57. doi: 10.1111/j.1360-0443.2008.02269.x.
3
Medical and support service utilization in a medical program targeting marginalized HIV-infected individuals.
J Health Care Poor Underserved. 2008 Aug;19(3):981-90. doi: 10.1353/hpu.0.0035.
4
Delivering care out of the box: the evolution of an HIV harm reduction medical program.
J Health Care Poor Underserved. 2008 Aug;19(3):944-51. doi: 10.1353/hpu.0.0051.
5
Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
Am J Drug Alcohol Abuse. 2008;34(2):161-70. doi: 10.1080/00952990701877052.
6
The feasibility of modified directly observed therapy for HIV-seropositive African American substance users.
AIDS Patient Care STDS. 2008 Feb;22(2):139-46. doi: 10.1089/apc.2007.0063.
7
Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users.
J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S35-47. doi: 10.1097/QAI.0b013e31815767c4.
8
Assessment of a medical outreach program to improve access to HIV care among marginalized individuals.
Am J Public Health. 2007 Oct;97(10):1758-61. doi: 10.2105/AJPH.2006.090878. Epub 2007 Aug 29.
9
Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
AIDS Patient Care STDS. 2007 Aug;21(8):564-74. doi: 10.1089/apc.2006.0192.
10
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Int J Drug Policy. 2007 Aug;18(4):262-70. doi: 10.1016/j.drugpo.2006.12.014. Epub 2007 Jan 26.
Zotero 插件